Compound K suppresses myeloid-derived suppressor cells in a mouse model bearing CT26 colorectal cancer xenograft.
- Author:
Rong WANG
1
;
Yalin LI
;
Wuzhou WANG
;
Meijuan ZHOU
;
Zhaohui CAO
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Apoptosis; Cell Proliferation; Colorectal Neoplasms; pathology; Disease Models, Animal; Ginsenosides; pharmacology; Humans; Immunosuppression; Interleukin-17; metabolism; Interleukin-1beta; metabolism; Interleukin-6; metabolism; Mice; Mice, Inbred BALB C; Myeloid Cells; drug effects; Neoplasm Transplantation
- From: Journal of Southern Medical University 2015;35(5):748-752
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of ginseng-derived compound K (C-K) on apoptosis, immunosuppressive activity, and pro-inflammatory cytokine production of myeloid-derived suppressor cells (MDSCs) from mice bearing colorectal cancer xenograft.
METHODSFlow-sorted bone marrow MDSCs from Balb/c mice bearing CT26 tumor xenograft were treated with either C-K or PBS for 96 h and examined for apoptosis with Annexin V/7-AAD, Cox-2 and Arg-1 expressions using qRT-PCR, and supernatant IL-1β, IL-6, and IL-17 levels with ELISA. C-K- or PBS-treated MDSCs were subcutaneously implanted along with CT26 tumor cells in WT Balb/c mice, and the tumor size and morphology were evaluated 21 days later.
RESULTSC-K treatment significantly increased the percentages of early and late apoptotic MDSCs in vitro (P<0.01 and P<0.05, respectively), decreased the expressions of immunosuppression-related genes Cox-2 (P<0.05) and Arg-1 (P<0.01), and suppressed the production of IL-1β (P<0.05), IL-6 (P<0.01), and IL-17 (P<0.05) by the MDSCs . Compared with PBS-pre-treated cells, C-K-pretreated MDSCs showed significantly attenuated activity in promoting CT26 tumor growth in mice (P<0.01).
CONCLUSIONC-K can suppress the immunosuppresive effect of MDSCs to inhibit tumor cell proliferation in mice, which suggests a new strategy of tumor therapy by targeting MDSCs.